Tekla Capital Management LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 190 filers reported holding IMMUNOGEN INC in Q2 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2020$1,085,000
+79.3%
168,1900.0%0.04%
+65.2%
Q3 2020$605,000
-21.8%
168,1900.0%0.02%
-20.7%
Q2 2020$774,000
+34.8%
168,1900.0%0.03%
+11.5%
Q1 2020$574,000
-33.2%
168,1900.0%0.03%
-18.8%
Q4 2019$859,000
+111.1%
168,1900.0%0.03%
+77.8%
Q3 2019$407,000
+11.5%
168,1900.0%0.02%
+20.0%
Q2 2019$365,000
-20.0%
168,1900.0%0.02%
-21.1%
Q1 2019$456,000
-43.5%
168,1900.0%0.02%
-45.7%
Q4 2018$807,000
-49.3%
168,1900.0%0.04%
-39.7%
Q3 2018$1,593,000
-75.6%
168,190
-57.3%
0.06%
-93.5%
Q2 2013$6,533,000393,7730.89%
Other shareholders
IMMUNOGEN INC shareholders Q2 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders